Nurse Practitioner, Family · Burlington, MA
NPI
1407383136
Since 2017
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
Lahey Hospital and Medical Center, 41 Mall Road
Burlington, MA, 01805
Phone (781) 744-8400
Groups this clinician bills Medicare through
Medicare paid, 2024
$34K
438 services
Medicare patients, 2024
187
Average age 75
Drug cost, 2024
$6.6M
1,271 prescriptions
Company payments, 2025
$99.99
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rojer Ranjit was code 99214 (office e&m - established), 230 times for 106 patients. In total Rojer Ranjit billed 438 services in 5 codes, and Medicare paid $34K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-07-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 230 | 106 | $65.74 | $15K |
| 99215 Office E&M - Established | Facility | 119 | 65 | $97.28 | $12K |
| 99214 Office E&M - Established | Office | 45 | 43 | $78.02 | $3,511 |
| 99215 Office E&M - Established | Office | 26 | 21 | $101.16 | $2,630 |
By year: 2022 $20K for 238 services; 2023 $30K for 373 services; 2024 $34K for 438 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rojer Ranjit prescribed most often to Medicare patients was Abiraterone Acetate, with 251 prescriptions and refills. In total Rojer Ranjit wrote 1,271 Medicare prescriptions that cost $6.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Abiraterone Acetate Generic | 251 | 263 | 39 | $334K |
| Prednisone Generic | 178 | 289 | 52 | $796 |
| Nubeqa Darolutamide | 124 | 130 | 24 | $1.7M |
| Orgovyx Relugolix | 73 | 74 | 16 | $196K |
| Xtandi Enzalutamide | 73 | 77 | 14 | $1.1M |
| Tamsulosin Hcl Generic | 55 | 153 | 25 | $1,077 |
| Welireg Belzutifan | 45 | 45 | Under 11 | $1.3M |
| Erleada Apalutamide | 33 | 33 | Under 11 | $452K |
| Levothyroxine Sodium Generic | 30 | 79 | 15 | $215 |
| Eliquis Apixaban | 30 | 38 | Under 11 | $22K |
| Cabometyx Cabozantinib S-Malate | 25 | 25 | Under 11 | $605K |
| Lenvima Lenvatinib Mesylate | 25 | 25 | Under 11 | $573K |
| Venlafaxine Hcl Er Venlafaxine Hcl | 24 | 56 | Under 11 | $369 |
| Prochlorperazine Maleate Generic | 19 | 19 | 17 | $164 |
| Ondansetron Hcl Generic | 18 | 18 | 14 | $130 |
Brand drugs: 480 claims; generic drugs: 791 claims; opioid claims: 37.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rojer Ranjit $99.99 ($99.99 in general payments such as food, travel and fees) from 1 company. The largest payer was Janssen Biotech, Inc. with $99.99.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 1 | $99.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.